Sukhtian Ghiath M. has filed 10 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 4285714 shares of Outlook Therapeutics, Inc. ($OTLK) on May 27, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | A | Common Stock | 4285714 | $1.40 | 13,552,359.0000 | 30,874,396 | 46.25% | 13.88% |
| May 27, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | A | Warrants (right to buy) | 8571428 | $0.00 | 8,571,428.0000 | 30,874,396 | 9999.99% | 27.76% |
| Jan. 17, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | M | Common Stock | 3458571 | $2.51 | 9,266,645.0000 | 24,233,957 | 59.55% | 14.27% |
| Jan. 17, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | A | Warrants (right to buy) | 3458571 | $0.00 | 3,458,571.0000 | 24,233,957 | 9999.99% | 14.27% |
| Jan. 17, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | M | Warrants (right to buy) | 3458571 | $0.00 | 0.0000 | 24,233,957 | 100.00% | 14.27% |
| Jan. 17, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | A | Warrants (right to buy) | 3458571 | $0.00 | 3,458,571.0000 | 24,233,957 | 9999.99% | 14.27% |
| Jan. 17, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | D | Warrants (right to buy) | 3458571 | $0.00 | 0.0000 | 24,233,957 | 100.00% | 14.27% |
| Jan. 17, 2025 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | A | Warrants (right to buy) | 3458571 | $0.00 | 3,458,571.0000 | 24,233,957 | 9999.99% | 14.27% |
| March 18, 2024 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | A | Warrants (right to buy) | 3458571 | $0.00 | 3,458,571.0000 | 13,012,833 | 9999.99% | 26.58% |
| March 18, 2024 | Outlook Therapeutics, Inc. | $OTLK | Sukhtian Ghiath M. | Director | A | Common Stock | 2305714 | $0.00 | 5,808,074.0000 | 13,012,833 | 65.83% | 17.72% |